Completion of Share Buyback Programme

22 Dec 2025 12:50 CET

Coca-Cola Europacific Partners plc (the "Company")
Completion of Share Buyback Programme

The Company today announces that it has completed the share buyback programme (the "Programme") announced on 14 February 2025 to purchase up to a maximum aggregate amount of EUR 1 billion of the Company's ordinary shares.

The Company announces that 12,718,173 ordinary shares were repurchased under the Programme, for aggregate consideration of approximately EUR 999,998,769.23.[1]

As a result, the Company has returned EUR 999,998,769.23 to its shareholders through the completion of the Programme.

CONTACTS

ABOUT CCEP

Coca-Cola Europacific Partners is one of the world's leading consumer goods companies. We make, move and sell some of the world's most loved brands - serving nearly 600 million consumers and helping over 4 million customers across 31 countries grow.

We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support.

The Company is currently listed on Euronext Amsterdam, NASDAQ (and a constituent of the NASDAQ 100), London Stock Exchange and on the Spanish Stock Exchanges, trading under the symbol CCEP (ISIN No. GB00BDCPN049).

For more information about CCEP, please visit www.cocacolaep.com and follow CCEP on LinkedIn

[1] The aggregate consideration of approximately EUR 999,998,769.23 is comprised of USD 832,273,272 spent on acquiring shares on the US Trading Venues (which comprise Nasdaq and other applicable US trading venues) and GBP 234,969,006 spent on acquiring depository interests on the London Trading Venues (which comprise the London Stock Exchange, CBOE Europe Limited (BXE), CBOE Europe Limited (CXE) and Aquis) over the course of the Programme.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

95688_GB00BDCPN049.pdf